Safilo Group SpASAFLF 62 Days Payable is 155.54 as of Dec. 2025, which is 4% above its 10-year median of 150.13. GuruFocus rates SAFLF with a GF Score™ of 62/100 and a GF Value™ of $1.23 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Safilo Group SpA ranks better than 77.99% on this metric.
The historical rank and industry rank for Safilo Group SpA's Days Payable or its related term are showing as below:
SAFLF'
s Days Payable Range Over the Past 10 Years
Min: 135.8 Med: 150.13 Max: 163.27
Current: 147.42
During the past 13 years, Safilo Group SpA's highest Days Payable was 163.27. The lowest was 135.80. And the median was 150.13.
SAFLF's Days Payable is ranked better than 77.99% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs SAFLF: 147.42
Safilo Group SpA's Days Payable
declined
from Dec. 2024 (161.72) to Dec. 2025 (155.54).
It may suggest that Safilo Group SpAaccelerated paying its suppliers.
Safilo Group SpA Days Payable Related Terms
Safilo Group SpA Days Payable Historical Data
* Premium members only.
The historical data trend for Safilo Group SpA's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Safilo Group SpA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Safilo Group SpA Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Safilo Group SpA's Days Payable distribution charts can be found below:
* The bar in red indicates where Safilo Group SpA's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Safilo Group SpA's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Safilo Group SpA (SAFLF) has a Days Payable of 155.54 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Safilo Group SpA and its competitors. This is near median its historical median of 150.13. Over the past decade, Safilo Group SpA's Days Payable has ranged from 135.80 to 163.27. According to the industry distribution chart, Safilo Group SpA ranks #175 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 22%.
Is Safilo Group SpA's Days Payable too high?
Safilo Group SpA's current Days Payable of 155.54 is near median its 10-year median of 150.13. Over the past 10 years, this metric has ranged from a low of 135.80 to a high of 163.27. The Medical Devices & Instruments industry median Days Payable is 67.87. Safilo Group SpA's value of 155.54 is 129.2% above this industry median. Based on the distribution chart, Safilo Group SpA ranks #175 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Safilo Group SpA has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Safilo Group SpA's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Safilo Group SpA ranks #175 out of 795 companies for Days Payable. This places Safilo Group SpA in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Safilo Group SpA's value of 155.54 is 129.2% above this benchmark. Historically, Safilo Group SpA's own Days Payable has ranged from 135.80 to 163.27 over the past decade. While the company's 10-year median is 150.13 vs. the industry median of 67.87, Safilo Group SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Safilo Group SpA's current Days Payable of 155.54 is 129.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Safilo Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Safilo Group SpA's current Days Payable is 155.54, which is near median its own 10-year median of 150.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Safilo Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Safilo Group SpA (SAFLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.23, compared to a current price of $2.01 — trading 63.4% above its estimated fair value. The current Days Payable is 155.54, which is near median its 10-year median of 150.13 and 129.2% above the Medical Devices & Instruments industry median of 67.87. Safilo Group SpA's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Safilo Group SpA (SAFLF), the current Days Payable is 155.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Safilo Group SpA (SAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Safilo Group SpA stock appears to be overvalued.
The current stock price of $2.01 is trading 63.4% above its estimated GF Value™ of $1.23.
GuruFocus considers Safilo Group SpA to be Significantly Overvalued.
Key valuation signals for SAFLF:
Days Payable: 155.54 (near median its 10-year median of 150.13)
GF Value™: $1.23 vs. price of $2.01 (63.4% above fair value)
Industry Position: 129.2% above the Medical Devices & Instruments median (#175 of 795)
No single metric tells the full story. See the SAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Safilo Group SpA makes sunglasses and prescription eyewear. It is engaged in design, production, and wholesale distribution of its products through a network of independent distributors and commercial subsidiaries. Its products are sold through the Carrera, Smith, Polaroid and Oxydo brands, as well as a range of other licensed brands. The company operates solely through the wholesale segment channels and divides itself into the following four geographical segments: Europe, America, and Asia. The company earns the majority of its revenue from the Europe business segment.
62GF Score
Get the complete analysis for SAFLF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAFLF has been successfully added to your 
